Oversea Chinese Banking Corp LTD Bei Gene, Ltd. Transaction History
Oversea Chinese Banking Corp LTD
- $3.23 Billion
- Q2 2024
A detailed history of Oversea Chinese Banking Corp LTD transactions in Bei Gene, Ltd. stock. As of the latest transaction made, Oversea Chinese Banking Corp LTD holds 2,803 shares of BGNE stock, worth $629,301. This represents 0.01% of its overall portfolio holdings.
Number of Shares
2,803
Previous 4,875
42.5%
Holding current value
$629,301
Previous $762,000
47.64%
% of portfolio
0.01%
Previous 0.03%
Shares
11 transactions
Others Institutions Holding BGNE
# of Institutions
212Shares Held
45.1MCall Options Held
106KPut Options Held
93.1K-
Baker Bros. Advisors LP New York, NY10.6MShares$2.37 Billion20.04% of portfolio
-
Capital International Investors Los Angeles, CA7.01MShares$1.57 Billion0.21% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E95.18MShares$1.16 Billion19.1% of portfolio
-
Primecap Management CO Pasadena, CA4.99MShares$1.12 Billion0.52% of portfolio
-
Baillie Gifford & CO3.68MShares$827 Million0.42% of portfolio
About BeiGene, Ltd.
- Ticker BGNE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 103,700,000
- Market Cap $23.3B
- Description
- BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...